Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Study Overview
=================
Brief Summary
-----------------
RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future. PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.

Detailed Description
-----------------
OBJECTIVES: Primary To collect clinical data and family histories and blood and/or tissue samples from patients diagnosed with pancreatic diseases, including pancreatic cancer, for use in future studies. To collect information regarding food preparation and intake in these patients. Secondary To make available to researchers medical data and biospecimens to enable them to develop better ways to screen people at risk for pancreatic conditions, including pancreatic cancer. To investigate genes or substances that increase susceptibility of developing pancreatic conditions. To find agents that may help prevent, treat, or cure these conditions. To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers. OUTLINE: This is a multicenter study. Patients complete two 1-hour surveys assessing health, clinical and family history of pancreatic conditions including cancer, and food preparation and intake. Patients also complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health practices, and family history. A review of the patient's medical information is obtained from the medical record. Blood samples are collected for future research studies. Oral cells and stool samples may also be collected for future studies.

Official Title
-----------------
Biospecimen Resource for Pancreas Research, a Data & Tissue Bank (Also Known as a Bio-repository, Bio-bank, Data & Tissue Database, Data & Tissue Registry, Etc.) to Help Advance Research in Pancreas Disease

Conditions
-----------------
Islet Cell Tumor, Pancreatic Cancer, Pancreatic Disease

Intervention / Treatment
-----------------
* Other: medical chart review
* Other: survey administration
* Other: biospecimen collection


Participation Criteria
=================
Eligibility Criteria
-----------------
DISEASE CHARACTERISTICS: Diagnosis or suspicion of at least one of the following: Pancreatic cancer Pancreatic mass Islet cell tumor PATIENT CHARACTERISTICS: Able to understand and read English Mentally competent and able to provide informed consent Has not donated blood within the past 8 weeks PRIOR CONCURRENT THERAPY: At least 7 days since prior blood transfusion At least 7 days since prior surgery

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 120 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: medical chart review|baseline, 12 month and 36 months|
|Other: survey administration|baseline, 6 month, 12 month|
|Other: biospecimen collection|baseline|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Collection of clinical data, health and family histories by survey |  | baseline enrollment, 6 months, 12 months | 
| Collection of blood and/or tissue, fecal and oral specimens |  | baseline | 
| Collection of information regarding food preparation and intake by survey |  | baseline | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
recurrent pancreatic cancer, stage I pancreatic cancer, stage II pancreatic cancer, stage III pancreatic cancer, stage IV pancreatic cancer, recurrent islet cell carcinoma, pancreatic alpha cell carcinoma, pancreatic beta islet cell carcinoma, pancreatic delta cell carcinoma, pancreatic G-cell carcinoma